Workflow
蓝丰生化2025年中报简析:营收上升亏损收窄,盈利能力上升

Financial Performance - The company reported a total revenue of 1.196 billion yuan for the first half of 2025, representing a year-on-year increase of 40.89% [1] - The net profit attributable to shareholders was -44.779 million yuan, showing a year-on-year improvement of 67.87% [1] - In Q2 2025, the revenue reached 652 million yuan, up 38.5% year-on-year, while the net profit attributable to shareholders was -22.624 million yuan, an increase of 79.22% year-on-year [1] Profitability Metrics - The gross margin improved to 2.76%, with a year-on-year increase of 213.27%, while the net margin was -5.36%, reflecting a year-on-year increase of 74.35% [1] - The total of selling, administrative, and financial expenses was 81.677 million yuan, accounting for 6.83% of revenue, a decrease of 31.96% year-on-year [1] Shareholder Metrics - The earnings per share (EPS) improved to -0.12 yuan, a year-on-year increase of 69.79% [1] - The net asset per share was -0.02 yuan, showing a year-on-year increase of 94.09% [1] - The operating cash flow per share was -0.36 yuan, a significant decrease of 295.05% year-on-year [1] Historical Performance - The company has a median Return on Invested Capital (ROIC) of -24.19% over the past decade, with the worst year being 2022 at -51.19% [3] - The company has reported losses in 8 out of 14 annual reports since its listing, indicating a generally poor financial history [3] Cash Flow and Financial Health - The cash flow situation is concerning, with cash and cash equivalents to current liabilities ratio at 38.1% and a negative average operating cash flow to current liabilities ratio over the past three years [3] - The company has faced challenges with accounts receivable, as indicated by negative net profit attributable to shareholders in annual reports [3]